SENOVIE France - Therapeutic Mobility and Breast Cancer

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

Background In France, there were 61,214 new cases of breast cancer in France in 2023 with an estimated prevalence in 2017 of 913,089 people. It is thus the most common cancer in women, with an incidence that has been increasing since 1990, due both to changes in screening but more recently to a moderate increase in relation to changes in risk factors. Social inequalities in breast cancer are documented, but there are no data on immigrant women, and there is reason to believe that their trajectories may be different from those of women born in France (characteristics and age of cancer onset, problems of access to care, isolation, etc.). The SENOVIE France project aims to better understand the impact of breast cancer on the life trajectories of women born in France and women born in sub-Saharan Africa. Objectives The SENOVIE France survey aims : * To understand how breast cancer (diagnosis, treatment, and breast reconstruction) impacts women's lives that are already affected by migration in many spheres (i.e., social consequences of breast cancer on spheres like family or occupation/financial situation). * To study the therapeutic itineraries (including self-reconstruction) of immigrant women living with breast cancer in the greater Paris area and understand their social determinants. * To observe how gender can shape women's medical and social outcomes in a migration context. Methodology The SENOVIE France survey is a mixed-methods survey with a quantitative and a qualitative component. The quantitative component consists of a quantitative, retrospective, life-event survey carried out among 1000 women living with breast cancer and followed in three health services in the greater Paris area. Women born in France and sub-Saharan Africa will be surveyed. This survey consists of a CAPI patient questionnaire and a biographical grid paper (for the life-event data collection) administered face-to-face by specially trained interviewers, as well as a medical questionnaire completed by the team of the health services concerned. Statistical analyses adapted to longitudinal data will be used to study women's trajectories. The qualitative component consists of a survey by semi-structured interviews with women living with breast cancer and followed in the greater Paris area. These interviews are the subject of an audio recording and then a pseudonymized transcription. Thematic analyses will be carried out with a comprehensive approach that aims to analyze women's experiences. Perspectives and expected results This survey will provide scientific knowledge on the diagnosis, treatment and experience of breast cancer and its impact on the life trajectories of women born in France and sub-Saharan Africa. These results could thus contribute to the improvement of medical and psychosocial care for women living with breast cancer.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Women aged 18 or more

• Women who consult in one of the partner hospitals of the study

• For groups 1: women born in a country of sub-Saharan Africa

• For group 2: women born in France

• Have been diagnosed with breast cancer between the 1st of January 2014 and the 31st of December 2020. As data collection will start in 2024, this is to be able to examine women's life trajectories at least 4 years after cancer diagnosis, and maximum 10 years after their diagnosis, which is the length of the follow-up in hospital services where recruitment will take place.

Locations
Other Locations
France
Robert Ballanger Hospital Aulnay-Sous-Bois
NOT_YET_RECRUITING
Aulnay-sous-bois
Saint-Louis University Hospital AP-HP
RECRUITING
Paris
Delafontaine Hospital Saint-Denis
NOT_YET_RECRUITING
Saint-denis
Contact Information
Primary
Clémence Schantz, PhD
clemence.schantz@ird.fr
0176533470
Backup
Anne Gosselin, PhD
anne.gosselin@ined.fr
0156062045
Time Frame
Start Date: 2024-03-25
Estimated Completion Date: 2025-03-31
Participants
Target number of participants: 1000
Treatments
Women born in sub-Saharan Africa
Women born in sub-Saharan Africa and diagnosed with breast cancer
Women born in France
Women born in France and diagnosed with breast cancer
Related Therapeutic Areas
Sponsors
Leads: Institut de Recherche pour le Developpement
Collaborators: The French Collaborative Institute on Migrations, Centre Hospitalier Intercommunal Robert Ballanger, Ceped UMR 196, Université Paris Cité, The French National Cancer Institute, The French Institute for Demographic Studies (INED), Saint-Louis Hospital, Paris, France, Centre Hospitalier de Saint-Denis

This content was sourced from clinicaltrials.gov